← Back to Search

Compass Course for COVID-19 (CC-COVID Trial)

N/A

Waitlist Available

Led By Mary V Radomski, OTR/L, PhD

Research Sponsored by Allina Health System

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18 - 80 years

Part of the Allina Health COVID Research Registry or receiving/have received therapy services for COVID-19 related sequelae at CKRI

Timeline

Screening 3 weeks

Treatment Varies

Follow Up will be assessed at baseline (week 0) and completion (following session 8, week 12)

Awards & highlights

CC-COVID Trial Summary

This trial will help to assess whether the Compass Course is efficacious in helping individuals who were hospitalized with COVID-19 to reframe a sense of self and reaffirm or reconstruct a sense of purpose in their daily lives.

Who is the study for?

This trial is for adults aged 18-80 who were hospitalized with COVID-19 and are now part of the Allina Health COVID Research Registry or receiving therapy at CKRI. Participants must have completed high school, be able to use technology for video calls, commit to all sessions, own a smartphone, and speak English. Those with neurological disorders or conditions affecting daily activities cannot join.Check my eligibility

What is being tested?

The Compass Course intervention being tested aims to improve psychological well-being and purpose in life post-COVID-19 hospitalization. It includes education and support over eight sessions spanning 2-3 months focused on six dimensions of flourishing. Efficacy will be evaluated through questionnaires during a focus group session two months after completion.See study design

What are the potential side effects?

Since this intervention involves educational and supportive sessions rather than medical treatments, traditional side effects are not expected. However, participants may experience emotional discomfort while reflecting on personal experiences during the course.

CC-COVID Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 80 years old.

Select...

I am part of the Allina Health COVID Research Registry or have received therapy for COVID-19 aftereffects at CKRI.

CC-COVID Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ will be assessed at baseline (week 0) and completion (following session 8, week 12)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~will be assessed at baseline (week 0) and completion (following session 8, week 12)

This trial's timeline: 3 weeks for screening, Varies for treatment, and will be assessed at baseline (week 0) and completion (following session 8, week 12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Psychological Wellbeing

Secondary outcome measures

Change in Meaning in Life Questionnaire

Change in Purpose Status Question

CC-COVID Trial Design

1Treatment groups

Experimental Treatment

Group I: Compass CourseExperimental Treatment1 Intervention

Four groups of up to 12 participants (48 total) will receive the study intervention during Spring and Fall 2022. All participants will complete study questionnaires before and after the sessions.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Compass Course

2018

N/A

~70

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Allina Health SystemLead Sponsor

56 Previous Clinical Trials

1,175,166 Total Patients Enrolled

Mary V Radomski, OTR/L, PhDPrincipal InvestigatorAllina Health

1 Previous Clinical Trials

20 Total Patients Enrolled

Media Library

COVID-19 Research Study Groups: Compass Course

COVID-19 Clinical Trial 2023: Compass Course Highlights & Side Effects. Trial Name: NCT05295238 — N/A

Compass Course 2023 Treatment Timeline for Medical Study. Trial Name: NCT05295238 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is the ideal candidate to be included in this clinical experiment?

"This trial is recruiting 48 individuals who have already contracted covid-19, and are aged between 18 to 80 years old. Additional selection criteria include being able to understand English, having completed high school or equivalent qualifications, possessing the capacity for sight, sound and speech (with or without aid), access to a computer/smartphone with an adequate internet connection; compatible device software such as iOS 9.0 - 14.4 or Android 8.1 - 11; consenting to download mEMA application notifications and participating in all intervention sessions."

Answered by AI

Is enrollment still available for this experiment?

"According to clinicaltrials.gov, this investigation is presently seeking volunteers for involvement; the trial was published on March 7th 2021 and underwent its most recent update on March 23rd 2022."

Answered by AI

How extensive is the participant list for this medical research?

"Affirmative. Clinicaltrials.gov records verify that this clinical trial was posted on March 7th 2022 and is currently recruiting patients. The study seeks to enrol 48 people from a single medical centre."

Answered by AI

Is the age limit for this research study below sixty years old?

"This trial is seeking participants between the ages of 18 and 80. In contrast, there are 139 other clinical trials for minors, as well as 905 medical studies open to individuals over 65 years old."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Compass Course: COVID-19

Mary Radomski 2022. "Compass Course: COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05295238.